Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancer.
Npj Breast Cancer
Luo, Rui R; Chong, Weelic W; Wei, Qiang Q; Zhang, Zhenchao Z; Wang, Chun C; Ye, Zhong Z; Abu-Khalaf, Maysa M MM; Silver, Daniel P DP; Stapp, Robert T RT; Jiang, Wei W; Myers, Ronald E RE; Li, Bingshan B; Cristofanilli, Massimo M; Yang, Hushan H
mTOR Signaling and SREBP Activity Increase FADS2 Expression and Can Activate Sapienate Biosynthesis.
Cell Reports
Triki, Mouna M; Rinaldi, Gianmarco G; Planque, Melanie M; Broekaert, Dorien D; Winkelkotte, Alina M AM; Maier, Carina R CR; Janaki Raman, Sudha S; Vandekeere, Anke A; Van Elsen, Joke J; Orth, Martin F MF; Grünewald, Thomas G P TGP; Schulze, Almut A; Fendt, Sarah-Maria SM
NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers.
Molecular Oncology
Bertucci, François F; Rypens, Charlotte C; Finetti, Pascal P; Guille, Arnaud A; Adélaïde, José J; Monneur, Audrey A; Carbuccia, Nadine N; Garnier, Séverine S; Dirix, Piet P; Gonçalves, Anthony A; Vermeulen, Peter P; Debeb, Bisrat G BG; Wang, Xiaoping X; Dirix, Luc L; Ueno, Naoto T NT; Viens, Patrice P; Cristofanilli, Massimo M; Chaffanet, Max M; Birnbaum, Daniel D; Van Laere, Steven S
Integrative omics analyses broaden treatment targets in human cancer.
Genome Medicine
Sengupta, Sohini S; Sun, Sam Q SQ; Huang, Kuan-Lin KL; Oh, Clara C; Bailey, Matthew H MH; Varghese, Rajees R; Wyczalkowski, Matthew A MA; Ning, Jie J; Tripathi, Piyush P; McMichael, Joshua F JF; Johnson, Kimberly J KJ; Kandoth, Cyriac C; Welch, John J; Ma, Cynthia C; Wendl, Michael C MC; Payne, Samuel H SH; Fenyö, David D; Townsend, Reid R RR; Dipersio, John F JF; Chen, Feng F; Ding, Li L
Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.
Plos One
Prentice, Leah M LM; Miller, Ruth R RR; Knaggs, Jeff J; Mazloomian, Alborz A; Aguirre Hernandez, Rosalia R; Franchini, Patrick P; Parsa, Kourosh K; Tessier-Cloutier, Basile B; Lapuk, Anna A; Huntsman, David D; Schaeffer, David F DF; Sheffield, Brandon S BS
Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Carvajal, Richard D RD; Lawrence, Donald P DP; Weber, Jeffrey S JS; Gajewski, Thomas F TF; Gonzalez, Rene R; Lutzky, Jose J; O'Day, Steven J SJ; Hamid, Omid O; Wolchok, Jedd D JD; Chapman, Paul B PB; Sullivan, Ryan J RJ; Teitcher, Jerrold B JB; Ramaiya, Nikhil N; Giobbie-Hurder, Anita A; Antonescu, Cristina R CR; Heinrich, Michael C MC; Bastian, Boris C BC; Corless, Christopher L CL; Fletcher, Jonathan A JA; Hodi, F Stephen FS